References
Johnson, T.A. & Press, O.W. Ann. Hematol. 4, 175–182 (2000).
McLaughlin, P. et al. J. Clin. Oncol. 16, 2825–2833 (1998).
Chang, T.W. Nat. Biotechnol. 18, 157–162 (2000).
Söderlind, E., Carlsson, R., Borrebaeck, C.A.K & Ohlin M. Comb. Chem. High Throughput Screen. 4, 409–416 (2001).
Fishwild, D.M. et al. Nat. Biotechnol. 14, 845–851 (1996).
Soderlind, E. et al. Nat. Biotechnol. 8, 852–856 (2000).
Knappik, A. et al. J. Mol. Biol. 296, 57–86 (2000).
Sblattero, D. & Bradbury, A. Nat. Biotechnol. 18, 75–80 (2000).
Jirholt, P., Borrebaeck, C.A.K. & Ohlin, M. J. Mol. Biol. 318, 407–416 (2002).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Borrebaeck, C., Ohlin, M. Antibody evolution beyond Nature. Nat Biotechnol 20, 1189–1190 (2002). https://doi.org/10.1038/nbt1202-1189
Issue Date:
DOI: https://doi.org/10.1038/nbt1202-1189
- Springer Nature America, Inc.
This article is cited by
-
Recombinant antibodies and their use in biosensors
Analytical and Bioanalytical Chemistry (2012)
-
New technologies in cancer. Protein microarrays for biomarker discovery
Clinical and Translational Oncology (2011)